ANI PHARMACEUTICALS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $286.5M | $333.9M | $100.3M |
| FY2022 | $285.7M | $313.7M | $48.2M |
| FY2023 | $284.8M | $432.7M | $221.1M |
| FY2024 | $309.1M | $403.7M | $144.9M |
| FY2025 | $291.8M | $540.7M | $285.6M |